DOT UPRISE WILL TAKEOVER
Affirmed inversion, Polkadot Buy Signal from Script set off: EMA Crossover SMA just beneath the 23.60% fibonacci level, 43% addition from here to retest the 200 MA. Use purchase zone to plan your purchases. Swing objective from here is 160% addition from $18.92 to $49.75.
Current Price Targets: $25, $34, $49 and Swing @ $60. Glad Trading :)
See past investigation underneath.
Polkadot (Dot) Buy opportunity! Expected 50%+ Gain to set a New ATH of $50 at the 161.8% Fibonacci Level. Spot's value took off to a high of $42 on 20/02/21. Since setting this new ATH , it has lost some force, following down to a low of $26 on the 23/02/21 get-togethers a rash move, yet at present it is as yet exchanging 45% over this low 4days back on the 23/02/21.
The essential viewpoint for Dot in the long haul is extraordinary and still particularly bullish , its absolute Market Cap is at $33.7 billion and right now positioned sixth greatest advanced cash on the planet after Bitcoin , Ethereum , Cardano, Binance Coin and Tether. Over the coming month we anticipate that Dot should retest the past ATH of $50 at the 161.8% Fibonacci expansion .
Current Price Targets: $25, $34, $49 and Swing @ $60. Glad Trading :)
See past investigation underneath.
Polkadot (Dot) Buy opportunity! Expected 50%+ Gain to set a New ATH of $50 at the 161.8% Fibonacci Level. Spot's value took off to a high of $42 on 20/02/21. Since setting this new ATH , it has lost some force, following down to a low of $26 on the 23/02/21 get-togethers a rash move, yet at present it is as yet exchanging 45% over this low 4days back on the 23/02/21.
The essential viewpoint for Dot in the long haul is extraordinary and still particularly bullish , its absolute Market Cap is at $33.7 billion and right now positioned sixth greatest advanced cash on the planet after Bitcoin , Ethereum , Cardano, Binance Coin and Tether. Over the coming month we anticipate that Dot should retest the past ATH of $50 at the 161.8% Fibonacci expansion .
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.